# Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)

> **NCT04894721** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ministry of Public Health, Argentina** · enrollment: 172 (actual)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04894721
- **Lead sponsor:** Ministry of Public Health, Argentina
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-01
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2021-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04894721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04894721, "Prophylaxis for COVID-19: Ivermectin in Close Contacts of COVID-19 Cases (IVERNEX-TUC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04894721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*